Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Environ Anal Chem ; 96(1): 15-37, 2016.
Article in English | MEDLINE | ID: mdl-33746339

ABSTRACT

Portable instruments based on X-Ray Fluorescence Spectrometry (XRF) have the potential to assist in field-based studies provided the data produced are reliable. In this study, we evaluate the performance of two different types of XRF instrument (XOS prototype, and Thermo Niton XL3t). These two XRF analyzers were evaluated in a laboratory setting, and data were reported for 17 elements (As, Ba, Cd, Co, Cr, Cu, Fe, Hg, Mn, Ni, Pb, Se, Sn, Sr, Ti, V, and Zn). Samples analyzed (n=38) included ethnic herbal medicine products (HMP), ethnic spices (ES), and cosmetic products (CP). Comparison analyses were carried out using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). In general, results reported for Cd, Cu and Pb by the XOS prototype analyzer, and based on the instrument's non-metal mode, were negatively biased (5 % to 95 %) compared to ICP-OES. In contrast, results reported for Pb, As, Cd, Cu and Zn by the Niton, based on using the soil mode, were positively biased, in some instances (Cd) by up to 4 orders of magnitude. While the sensitivity of both instruments was insufficient for reliably "quantifying" toxic elements below 15 mg/kg, XRF was still capable of positively "detecting" many elements at the low single digit mg/kg levels. However, for semi-quantification estimates of contaminants at higher levels, and with limited sample preparation, both XRF instruments were deemed fit for the purpose. This study demonstrates that modern XRF instrumentation is valuable for characterizing the elemental content of food, cosmetic, and medicinal products. The technology is particularly useful for rapidly screening large numbers of products (100s per day) in the field, and quickly identifying those that may contain potentially hazardous levels of toxic elements. Toxic elements can be confirmed by examining the raw spectrum, and the limitations of factory-based calibration are generally manageable for field-based studies.

2.
J Toxicol Environ Health A ; 75(21): 1253-68, 2012.
Article in English | MEDLINE | ID: mdl-23030652

ABSTRACT

Assessment of trace elements such as Cu, Zn, and Se in patients with neurodegenerative disease, such as Alzheimer's (AD) and Parkinson's disease (PD), may be useful in etiologic studies and in assessing the risk of developing these conditions. A prototype point-of-care (POC) instrument based on monochromatic x-ray fluorescence (M-XRF) was assembled and evaluated for the determination of Cu, Zn, and Se in whole blood, plasma, and urine. The prototype instrument was validated using certified reference materials for Cu and Zn in serum/plasma, and the reported bias and relative imprecision were <10%. The M-XRF prototype performance was further assessed using human specimens collected from AD and PD subjects, and was found to be satisfactory (<20% bias) for monitoring Cu and Zn levels in plasma and whole blood. However, the prototype M-XRF sensitivity was not sufficient for quantifying Cu, Zn, or Se in urine. Nonetheless, while validating the prototype instrument, body fluids (whole blood, plasma, and urine) were collected from 19 AD patients, 23 PD patients, and 24 controls specifically for trace element analysis using well-validated methods based on inductively coupled plasma mass spectrometry (ICP-MS). This limited biomonitoring study provided robust data for up to 16 elements including Sb, As, Ba, Cd, Cs, Co, Cr, Cu, Hg, Pb, Mo, Se, Tl, Sn, Zn, and U in plasma, whole blood, and urine. The results did not indicate any significant differences in most trace elements studied between AD or PD patients compared to controls, although the sample size is limited. A statistically significant increase in plasma Se was identified for PD patients relative to AD patients, but this could be due to age differences.


Subject(s)
Neurodegenerative Diseases/blood , Point-of-Care Systems , Spectrometry, X-Ray Emission/instrumentation , Trace Elements/blood , Aged , Alzheimer Disease/blood , Alzheimer Disease/urine , Case-Control Studies , Copper/blood , Copper/urine , Female , Humans , Male , Neurodegenerative Diseases/urine , Parkinson Disease/blood , Parkinson Disease/urine , Selenium/blood , Selenium/urine , Sensitivity and Specificity , Spectrometry, X-Ray Emission/methods , Trace Elements/urine , Zinc/blood , Zinc/urine
3.
Acta Neuropathol ; 118(6): 763-76, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19727777

ABSTRACT

Atrophy of dorsal root ganglia (DRG) and thinning of dorsal roots (DR) are hallmarks of Friedreich's ataxia (FRDA). Many previous authors also emphasized the selective vulnerability of larger neurons in DRG and thicker myelinated DR axons. This report is based on a systematic reexamination of DRG, DR and ventral roots (VR) in 19 genetically confirmed cases of FRDA by immunocytochemistry and single- and double-label immunofluorescence with antibodies to specific proteins of myelin, neurons and axons; S-100alpha as a marker of satellite and Schwann cells; laminin; and the iron-responsive proteins ferritin, mitochondrial ferritin, and ferroportin. Confocal images of axons and myelin allowed the quantitative analysis of fiber density and size, and the extent of DR and VR myelination. A novel technology, high-definition X-ray fluorescence (HDXRF) of polyethylene glycol-embedded fixed tissue, was used to "map" iron in DRG. Unfixed frozen tissue of DRG in three cases was available for the chemical assay of total iron. Proliferation of S-100alpha-positive satellite cells accompanied neuronal destruction in DRG of all FRDA cases. Double-label visualization of peripheral nerve myelin protein 22 and phosphorylated neurofilament protein confirmed the known loss of large myelinated DR fibers, but quantitative fiber counts per unit area did not change. The ratio of myelinated to neurofilament-positive fibers in DR rose significantly from 0.55 to 0.66. In VR of FRDA patients, fiber counts and degree of myelination did not differ from normal. Pooled histograms of axonal perimeters disclosed a shift to thinner fibers in DR, but also a modest excess of smaller axons in VR. Schwann cell cytoplasm in DR of FRDA was depleted while laminin reaction product remained prominent. Numerous small axons clustered around fewer Schwann cells. Ferritin in normal DRG localized to satellite cells, and proliferation of these cells in FRDA caused wide rims of reaction product about degenerating nerve cells. Mitochondrial ferritin was not detectable. Ferroportin was present in the cytoplasm of normal satellite cells and neurons, and in large axons of DR and VR. In FRDA, some DRG neurons lost their cytoplasmic ferroportin immunoreactivity, whereas the cytoplasm of satellite cells remained ferroportin positive. Ferroportin in DR axons disappeared in parallel with atrophy of large fibers. HDXRF of DRG detected regional and diffuse increases in iron fluorescence that matched ferritin expression in satellite cells. The observations support the conclusions that satellite cells and DRG neurons are affected by iron dysmetabolism; and that regeneration and inappropriate myelination of small axons in DR are characteristic of the disease.


Subject(s)
Friedreich Ataxia/metabolism , Ganglia, Spinal/metabolism , Iron/metabolism , Spinal Cord/metabolism , Adolescent , Adult , Aged , Axons/metabolism , Child , Female , Fluorescent Antibody Technique , Humans , Immunohistochemistry , Male , Middle Aged , Myelin Sheath/metabolism , Neurons/metabolism , Schwann Cells/metabolism
4.
Acta Neuropathol ; 116(4): 371-82, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18696091

ABSTRACT

Chronic or intermittent extravasations of blood into the subarachnoid space, and dissemination of heme by circulating cerebrospinal fluid, are the only established causes of superficial siderosis of the central nervous system (CNS). We studied the autopsy tissues of nine patients by iron histochemistry, immunocytochemistry, single- and double-label immunofluorescence, electron microscopy of ferritin, and high-definition X-ray fluorescence. In one case, frozen brain tissue was available for quantitative assay of total iron and ferritin. Siderotic tissues showed extensive deposits of iron and ferritin, and infiltration of the cerebellar cortex was especially severe. In addition to perivascular collections of hemosiderin-laden macrophages, affected tissues displayed iron-positive anuclear foamy structures in the neuropil that resembled axonal spheroids. They were especially abundant in eighth cranial nerves and spinal cord. Double-label immunofluorescence of the foamy structures showed co-localization of neurofilament protein and ferritin but comparable merged images of myelin-basic protein and ferritin, and ultrastructural visualization of ferritin, did not allow the conclusion that axonopathy was simply due to dilatation and rupture of fibers. Heme-oxygenase-1 (HO-1) immunoreactivity persisted in macrophages of siderotic cerebellar folia. Siderosis caused a large increase in total CNS iron but high-definition X-ray fluorescence of embedded tissue blocks excluded the accumulation of other metals. Holoferritin levels greatly exceeded the degree of iron accumulation. The susceptibility of the cerebellar cortex is likely due to Bergmann glia that serve as conduits for heme; and the abundance of microglia. Both cell types biosynthesize HO-1 and ferritin in response to heme. The eighth cranial nerves are susceptible because they consist of CNS axons, myelin, and neuroglial tissue along their subarachnoid course. The persistence of HO-1 protein implies continuous exposure of CNS to free heme or an excessively sensitive transcriptional response of the HO-1 gene. The conversion of heme iron to hemosiderin probably involves both translational and transcriptional activation of ferritin biosynthesis.


Subject(s)
Central Nervous System Diseases/pathology , Central Nervous System/pathology , Siderosis/pathology , Adult , Aged , Central Nervous System/metabolism , Central Nervous System Diseases/etiology , Central Nervous System Diseases/metabolism , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Cranial Nerves/metabolism , Cranial Nerves/pathology , Female , Ferritins/metabolism , Heme/cerebrospinal fluid , Heme Oxygenase-1/metabolism , Hemosiderin/metabolism , Humans , Iron/metabolism , Male , Microglia/metabolism , Microglia/pathology , Middle Aged , Retrospective Studies , Siderosis/etiology , Siderosis/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...